article thumbnail

Using analytics and bioassays to de-risk your mRNA LNP drug development programme

Pharmaceutical Technology

Another area where we tend to see problems is in encapsulation efficiency,” says Andrew Kondratowicz, Bioassay Team Lead, Precision NanoSystems. The bioassays are the canary in the coal mine of how well your process development is going. Where is your payload? Where is it allocated?

Bioassay 130
article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

coli expression systems and is using high-throughput expression pipelines to screen constructs for optimal expression to generate protein and cellular reagents. The Absolute Antibody team was available to discuss custom services, as well as the company’s comprehensive antibody reagent catalogue.

article thumbnail

Addressing the challenge of salt forms in drug discovery

Drug Discovery World

By selecting the correct salt form for an assay or as a reagent, scientists can optimise their research projects, says Andrievs Auseklis Auzin, Developer, Molport, Latvia. These can have better properties than their parents, including preferable stability, solubility, bioavailability, and manufacturability.

Drugs 52